GCNT2 and melanoma: Moreover, we found that GCNT2/I-branched glycans decreased IGF-1 and RGD ligand binding activity on melanoma cells, suggesting that GCNT2/I-branches may modulate IGF1R and fibronectin: integrin signaling through modulation of ligand binding capacity.